Vassiliki Saloura Selected Research

Vassiliki Saloura Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 01/2010
16	Squamous Cell Carcinoma of Head and Neck 01/2023 - 06/2014
5	Carcinogenesis 10/2023 - 02/2015
3	Head and Neck Neoplasms (Head and Neck Cancer) 10/2021 - 11/2019
3	Vesicular Stomatitis 09/2011 - 10/2009
2	Pneumonia (Pneumonitis) 06/2014 - 09/2011
2	Malignant Mesothelioma 04/2013 - 01/2010
2	Infections 09/2011 - 01/2010
2	Mesothelioma 01/2010 - 10/2009
1	Carcinoma (Carcinomatosis) 10/2023
1	Breast Neoplasms (Breast Cancer) 08/2018
1	Tongue Neoplasms (Tongue Neoplasm) 01/2018
1	Exanthema (Rash) 06/2014
1	Virus Diseases (Viral Diseases) 09/2011
1	Human Influenza (Influenza) 09/2011
1	Multiple Myeloma 10/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2010
1	Disease Progression 11/2009
1	Hodgkin Disease (Hodgkin's Disease) 11/2009

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2010
6	Protein MethyltransferasesIBA 11/2022 - 08/2015
6	Histones (Histone)IBA 01/2021 - 02/2015
4	EnzymesIBA 10/2020 - 02/2015
4	Lysine (L-Lysine)FDA Link 10/2020 - 02/2015
3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2017
3	MethyltransferasesIBA 01/2021 - 08/2015
2	ChemokinesIBA 10/2023 - 01/2019
2	pembrolizumabIBA 01/2023 - 12/2017
2	InterferonsIBA 01/2023 - 01/2010
2	ChromatinIBA 01/2021 - 10/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
2	Cetuximab (Erbitux)FDA Link 11/2019 - 06/2015
2	OTS167IBA 04/2019 - 08/2017
2	Small Interfering RNA (siRNA)IBA 04/2019 - 08/2017
2	Messenger RNA (mRNA)IBA 08/2017 - 01/2010
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2023
1	Transcription Factors (Transcription Factor)IBA 10/2023
1	Interferon Type IIBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2022
1	Monoclonal AntibodiesIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	NVP-BKM120IBA 11/2019
1	Phosphotransferases (Kinase)IBA 04/2019
1	2,3,6-trichloroindophenolIBA 01/2019
1	CateninsIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2018
1	NivolumabIBA 12/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2017
1	HLA-A Antigens (HLA-A)IBA 08/2017
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2017
1	Histone-Lysine N-MethyltransferaseIBA 07/2016
1	TNF-Related Apoptosis-Inducing LigandIBA 04/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2015
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2015
1	Histone MethyltransferasesIBA 02/2015
1	PlatinumIBA 06/2014
1	zalutumumabIBA 06/2014
1	Polyglutamic Acid (Polyglutamate)IBA 04/2013
1	Thymidylate SynthaseIBA 04/2013
1	Pemetrexed (MTA)FDA Link 04/2013
1	vadimezanIBA 09/2011
1	AcidsIBA 09/2011
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 09/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2010
1	Biomarkers (Surrogate Marker)IBA 10/2010
1	Lenalidomide (CC 5013)FDA Link 10/2010
1	Thalidomide (Thalomid)FDA Link 10/2010
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2010
1	Interferon-betaIBA 01/2010
1	eIF-2 Kinase (eIF 2 Kinase)IBA 01/2010
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2010

Therapy/Procedure

11	Therapeutics 10/2021 - 10/2009
5	Immunotherapy 01/2023 - 01/2019
3	Drug Therapy (Chemotherapy) 10/2021 - 11/2009
1	Radiotherapy 10/2021
1	Orthodontic Brackets 01/2018
1	Chemoradiotherapy 08/2017
1	Oncolytic Virotherapy 01/2010